Dermorphin: Reference Overview and Reconstitution Notes

Dermorphin is a natural opioid peptide (a small protein-like molecule) found in frog skin. It belongs to a group of research peptides studied for pain signaling and opioid receptors. It is not FDA-approved and is for research use only.

Dermorphin

What it is

Dermorphin is a natural opioid heptapeptide (a chain of exactly seven amino acids, the small building blocks that make up proteins). It was first found in the skin of South American frogs of the genus Phyllomedusa. Its amino acid sequence is Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2.

One thing that makes dermorphin unusual is that it contains a D-amino acid called D-alanine at position 2. Most amino acids in living things come in the "L" form. Think of L and D forms like your left and right hands. They look alike but are mirror images. This rare "D" form makes dermorphin harder for enzymes (the body's natural molecules that break other molecules apart) to cut up and destroy.

Key point: Dermorphin is an exceptionally potent, highly selective mu-opioid receptor agonist (meaning it binds strongly to a specific receptor involved in pain signaling and switches it on). It remains under scientific investigation and is strictly banned in competitive sports.

Research context and categorization

Dermorphin falls under the category of research peptides studied for pain signaling and opioid receptor pharmacology (the science of how molecules interact with receptors). Scientific literature describes it as binding very strongly and selectively to the mu-opioid receptor. Research sources often note that it is many times more potent than morphine at that receptor in laboratory tests.

In research settings, it is commonly used in studies of antinociception (the process by which pain signals are blocked). It also serves as a tool for studying how mu-opioid receptors bind to different molecules, and for examining opioid receptor subtypes. One effect studied in animal models is catalepsy (a temporary state of muscle rigidity and reduced movement, similar to a freeze response).

All of these uses are investigational. Dermorphin is not an approved therapy. Any effects described in the scientific literature are subjects of ongoing study, not confirmed or approved outcomes.

Status

• Regulatory status: Research use only. It is not FDA-approved for any human use. The scientific literature describes it as still under investigation.
• Sport status: Banned under the WADA Prohibited List (the global anti-doping agency's list of banned substances). It is classified as a prohibited narcotic during competition under the S7 Narcotics category. It has also drawn attention in horse racing, where it appeared on prohibited-substance lists in cases sometimes called the "frog juice" cases.

Reconstitution notes (general)

Dermorphin is typically supplied as a lyophilized (freeze-dried) powder, similar in concept to instant coffee granules, that you mix with liquid before using it at the lab bench. The working concentration follows a simple relationship:

• Concentration = Milligrams of peptide / Millilitres of bacteriostatic water added

For example, a 5 mg vial mixed with 2.5 mL of bacteriostatic water gives 2 mg/mL. You can work out volumes and target concentrations with the calculator at peptide calculator.

Dilution and handling notes (compound-specific)

Solubility and Concentration Limits

The most important handling fact for dermorphin is that it does not dissolve well in water. Think of it like sugar in a glass of water. There is a limit to how much will dissolve before you start seeing undissolved grains settling out. Dermorphin dissolves in water only up to about 2 mg/mL, so water-based preparations are usually kept at or below that level.

Trying to dissolve more than that limit will likely result in undissolved material, cloudiness, or a hazy mixture instead of a clear solution. The simple fix is to add more liquid to bring the concentration back within the range where the compound dissolves properly.

Vial Composition and Dilution

Research vials are commonly packaged with about 2 mg to 5 mg of solid material, often as the trifluoroacetate (TFA) salt form, packed under an inert gas to protect it. A salt form of a compound generally dissolves in water more easily than the plain compound alone.

Because dermorphin is active at very low concentrations in lab tests, it is more reliable to prepare a defined stock solution first and then dilute it step by step (called serial dilution) rather than trying to weigh out extremely tiny amounts directly. Some lab workflows that avoid water use a compatible organic solvent such as DMSO (dimethyl sulfoxide, a widely used lab solvent) to make a higher-concentration stock solution.

Handling Best Practices

When dissolving the powder in water, aim the liquid stream at the inside wall of the vial and swirl it gently. Avoid shaking the vial hard, since vigorous shaking can cause foaming or put damaging stress on the peptide.

Two more important quirks to keep in mind: the powder is hygroscopic, meaning it absorbs moisture from the surrounding air (the way table salt clumps on a humid day). Handle it quickly and reseal the vial right away. It is also light-sensitive, so keep it away from light during handling and storage. Storing the reconstituted solution in glass vials rather than plastic helps prevent the peptide from clinging to the container walls (a process called adsorption), which can cause losses in your sample.

Handling and storage

• Store the reconstituted solution in a refrigerator at 2 to 8 C, away from direct light.
• Wipe the vial stopper with an alcohol swab before drawing from it, and write the preparation date on the vial label.
• A refrigerated reconstituted solution is generally considered usable for about a 4-week window.
• Discard the solution if it becomes cloudy or discolored, or if you see floating particles.
• For long-term storage of unreconstituted powder, keep it frozen and sealed tightly against moisture.

Related reading

• DSIP (Delta Sleep-Inducing Peptide)
• Epitalon
• Follistatin
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is dermorphin and where does it come from?

Dermorphin is a naturally occurring heptapeptide first isolated from the skin of South American Phyllomedusa frogs. Its sequence is Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂, with a rare D-alanine at position 2 that resists enzymatic degradation.

What receptor does dermorphin bind to in laboratory studies?

Scientific literature describes dermorphin as a highly potent, selective mu-opioid receptor agonist, reported to be many times more potent than morphine at that receptor in vitro. It is used as a research tool in antinociception and receptor-binding studies.

How is dermorphin lyophilized powder reconstituted for lab use?

Calculate volume as mg ÷ target mg/mL (e.g., 5 mg ÷ 2 mg/mL = 2.5 mL bacteriostatic water). Inject solvent gently along the vial wall, swirl , do not shake , until dissolved, then label with concentration and date before storing per lab protocol.

What the research community gets wrong about dermorphin

• "More potent than morphine" is a receptor number, not a bench shortcut. The often-quoted figures come from receptor-binding and animal studies. They describe how tightly the peptide holds the mu-opioid receptor in those tests. They do not tell you how to dilute a vial or predict what a given stock concentration will do in your own assay.
• It is not freely soluble in water. Many people treat every peptide as if it dissolves without limit. Dermorphin dissolves in water only up to about 2 mg/mL. Push past that and you get cloudiness or undissolved grains, not a stronger clear solution.
• The D-alanine is real, not a typo. The position-2 D-alanine looks like a sequencing error to people used to all-L peptides, but it is a genuine, naturally occurring D-amino acid. Assuming it should be L can lead to ordering or comparing the wrong material.
• The salt form changes how much peptide you actually have. Vials are often the trifluoroacetate (TFA) salt. The number on the label may describe the salt mass, so the true peptide content can be a bit lower. Ignoring this throws off your calculated concentration.
• Selectivity is strong, not absolute, and it is easy to lose. Dermorphin is described as mu-selective, but small changes to the sequence (as seen in its close relatives) can shift the preference toward delta receptors. Treating any dermorphin analogue as if it behaves identically is a common mix-up.

From our bench: If you have reconstituted dermorphin in bacteriostatic water, we want your real solubility observation, not a spec-sheet number. At what concentration did your preparation first turn hazy or leave undissolved grains, and at what room temperature and swirl time did you check it? Tell us the exact concentration you reached before cloudiness appeared and we will add measured data points from real benches to this page.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem CID 5485199 , Dermorphin (NIH National Library of Medicine)
5. NCATS Inxight Drugs , Dermorphin, selective mu-opioid receptor agonist (NIH/NCATS)
6. Improta & Broccardo, [Lys7]dermorphin antinociception and mu-opioid affinity, Br J Pharmacol 1995 (PMC1510172)